Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $2.96, up $0.18, or 6.47%, on the day. Its market capitalization is $231.43 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting.
  • AVANIR Pharmaceuticals (NASDAQ:AVNR): The shares closed at $3.04, up $0.12, or 4.11%, on the day. Its market capitalization is $377.53 million. About the company: AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases.
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $4.46, up $0.13, or 3%, on the day. Its market capitalization is $108.57 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products.
  • Edwards Lifesciences Corp (NYSE:EW): The shares closed at $72.03, up $1.69, or 2.4%, on the day. Its market capitalization is $8.28 billion. About the company: Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
  • Affymax, Inc. (NASDAQ:AFFY): The shares closed at $5.01, up $0.1, or 2.04%, on the day. Its market capitalization is $178.13 million. About the company: Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.

Losers (% price change)

  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $3.02, down $0.33, or 9.85%, on the day. Its market capitalization is $165.75 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies.
  • Insmed Incorporated (NASDAQ:INSMD): The shares closed at $4.35, down $0.46, or 9.56%, on the day. Its market capitalization is $108.02 million. About the company: Insmed Incorporated is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
  • Cambrex Corporation (NYSE:CBM): The shares closed at $4.90, down $0.48, or 8.92%, on the day. Its market capitalization is $144.22 million. About the company: Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex’s services include process & analytical development, scale-up in addition to generic APIs.
  • Rockwell Medical Tech (NASDAQ:RMTI): The shares closed at $7.39, down $0.66, or 8.2%, on the day. Its market capitalization is $133.76 million. About the company: Rockwell Medical Technologies, Inc. manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. The Company offers Dri-State Dry Acid, Liquid Acid, SteriLyte Liquid Bicarbonate, Powder Bicarbonate, and ancillary dialysis items. Rockwell’s products are used to cleanse a patient’s blood and replace nutrients in the bloodstream.
  • DexCom, Inc. (NASDAQ:DXCM): The shares closed at $11.10, down $0.99, or 8.19%, on the day. Its market capitalization is $747.40 million. About the company: DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>